Table 2 Clinical finding of initial admission.

From: Contribution of sex and gender roles to the incidence of post-infectious irritable bowel syndrome in a prospective study

Variable

ALL

n = 231

No abdominal pain

n = 177

Abdominal pain

n = 54

P

No PI-IBS

n = 197

PI-IBS

n = 34

p

Fever (Days)

0.86 ± 0.97

0.81 ± 0.99

1.04 ± 0.910

0.130

0.85 ± 0.99

0.91 ± 0.830

0.745

Fever

 Presence

151

111

40

0.125

128

23

0.091

 Absence

80

66

14

 

69

11

 

Diarrhea (n)

7.05 ± 5.90

6.74 ± 5.90

8.06 ± 5.88

0.152

6.96 ± 5.93

7.56 ± 5.80

0.585

Peak CRP (mg/dL)

10.56 ± 6.09

8.99 ± 5.19

15.7 ± 6.07

< 0.01

10.10 ± 6.13

13.22 ± 5.21

 < 0.01

Antibiotics

   

0.803

  

0.090

 Ciprofloxacin

155

119

36

 

134

21

 

 Ciprofloxacin + Metronidazole

39

28

11

 

32

7

 

 Ceftriaxone

28

23

5

 

24

4

 

Ceftriaxone + Metronidazole

9

7

2

 

7

2

 

Duration of antibiotic use (days)

10.79 ± 1.79

10.58 ± 1.69

11.48 ± 1.95

< 0.01

10.68 ± 1.74

11.41 ± 1.94

0.046

Gender role identity

Androgynous

52

10

0.002

54

8

0.030

Masculine

50

11

53

8

Feminine

46

11

53

4

Undifferentiated

29

22

37

4

  1. BMI body mass index, CRP C-reactive protein, DM diabetes mellitus, HTN hypertension, PI-IBS post infectious irritable bowel syndrome.
Back to article page